Table 1.

Patient demographics and baseline characteristics, N=291

Female, n (%)	126 (43%)
Gestational age at start of recording, median weeks (range)	40.0 (34.1–47.6)
Preterma, n (%)	33 (11%)
Termb, n (%)	239 (82%)
Post-termc, n (%)	19 (7%)
Therapeutic hypothermia, n (%)	97 (33%)
Treatment with anti-seizure medication prior to cEEG, n (%)	97 (33%)
Indication for cEEG
Stereotyped clinical event (SCE), n (%)	142 (49%)
Acute neonatal encephalopathy (ANE), n (%)	101 (35%)
Other high-risk conditions (OHR), n (%)	48 (16%)
Cardiac or pulmonary risk factors	6 (2%)
CNS infection	12 (4%)
CNS trauma	7 (2%)
Genetic/syndromic disease	9 (3%)
Inborn errors of metabolism (IEM)	3 (1%)
Perinatal stroke	3 (1%)
Premature infants with additional risk factors	4 (1%)
Sinovenous thrombosis	4 (1%)

^(a)Preterm = 34- <37wk

^(b)Term = 37-<44 weeks

^(c)Post-term = 44- <48 weeks. cEEG = continuous EEG monitoring.